Edward Jones, policy and communications consultant at GK Strategy, provides an Expert View on how companies can take advantage of the UK National Health Service's (NHS) policy initiatives to support market access and uptake.
The NHS is one of the largest single markets for health innovations but despite being a single healthcare service, it remains notoriously difficult to spread innovative treatments, technologies and services across the system.
Adoption of a new product or service in one area does not necessarily mean it will be used across the system. This can be frustrating – both for suppliers and healthcare managers – and leaves suppliers reliant on nationwide sales teams to secure adoption on a trust-by-trust basis.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze